PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patients

Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer

(2021) Jie Yu et al.   BIOSCIENCE REPORTS

Checkpoint inhibitors for gastroesophageal cancers: dissecting heterogeneity to better understand their role in first-line and adjuvant therapy

(2021) E.C. Smyth et al.   ANNALS OF ONCOLOGY

Current treatment and recent progress in gastric cancer

(2021) Smita S. Joshi et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Construction and Validation of a Universal Applicable Prognostic Signature for Gastric Cancer Based on Seven Immune-Related Gene Correlated With Tumor Associated Macrophages

(2021) Junyu Huo et al.   Frontiers in Oncology

Cancer type-dependent correlations between TP53 mutations and antitumor immunity

(2020) Lin Li et al.   DNA REPAIR

Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer

(2020) Yueming Zhang et al.   Frontiers in Cell and Developmental Biology

Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432

(2019) F Wang et al.   ANNALS OF ONCOLOGY

Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients

(2019) Mina Nikanjam et al.   INTERNATIONAL JOURNAL OF CANCER

Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives

(2018) Julien Taieb et al.   CANCER TREATMENT REVIEWS

Molecular classification of gastric cancer

(2017) Christoph Röcken   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer

(2017) Marilyn M. Li et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Molecular classification of esophagogastric junction carcinoma correlated with prognosis

(2017) Long Zou et al.   OncoTargets and Therapy

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

(2015) Razvan Cristescu et al.   NATURE MEDICINE